Entera Bio (ENTX) Assets (2017 - 2026)
Entera Bio's Assets came in at $19.48 million for Q2 2026, down 1.0% from $19.67 million a year earlier but up 48.4% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Entera Bio's Assets was $15.99 million, up 70.3% from FY2024.
- Assets carries a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- Going back by year, Assets was $9.39 million in FY2024 (-20.2%), $11.77 million in FY2023 (-10.4%), $13.13 million in FY2022 (-49.5%) and $25.99 million in FY2021 (+167.3%).
- The five-year range for quarterly Assets is $7.74 million (Q3 2024) to $25.99 million (Q4 2021).
- Year-over-year, Assets increased in four of the last eight quarters, with growth averaging 41.5%.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 167.3%), and the weakest in Q4 2022 (a decline of 49.5%).
- Business Quant data shows ENTX's Assets at $13.13 million (Q1 2026), $15.99 million (Q4 2025) and $17.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Entera Bio | 132.59 Mn | 101.46 Mn | - | 19.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.48 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 15.99 Mn |
| Sep 30, 2025 | 17.41 Mn |
| Jun 30, 2025 | 19.67 Mn |
| Mar 31, 2025 | 21.60 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Mar 31, 2024 | 10.24 Mn |
| Dec 31, 2023 | 11.77 Mn |
| Sep 30, 2023 | 8.57 Mn |
| Jun 30, 2023 | 10.45 Mn |
| Mar 31, 2023 | 11.61 Mn |
| Dec 31, 2022 | 13.13 Mn |
| Sep 30, 2022 | 15.54 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 22.31 Mn |
| Dec 31, 2021 | 25.99 Mn |
| Jun 30, 2021 | 28.94 Mn |
API Access
Entera Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();